glp-1 agonist alcohol Therapeutics and Their Emerging Role in and Substance Use Disorders: An Endocrinology Primer A new clinical trial supported
Description
GLP-1R agonists are typically combined with metformin or other antidiabetic drugs
Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension
Patient Patient-Centered Outcomes Res 15(3):367377
The main adverse events of LIXI are gastrointestinal adverse reactions, mainly manifested as nausea and vomiting in the initial stage (75, 76)
Get irrefutable data about your diet and lifestyle by using your own glucose data with Vivelys CGM Program
If it works, the GLP-1 inhibitor could improve both metabolic issues and substance disorders
